In a small randomized trial, nebulized fentanyl produced better pain relief and satisfaction than intravenous morphine.
Fentanyl, a potent opioid with minimal hemodynamic effects, can be delivered by a variety of routes. In a randomized trial, investigators compared nebulized fentanyl (2 µg/kg) and intravenous morphine (0.1 mg/kg) for pain relief in 32 adult emergency department patients with acute abdominal pain. Fentanyl was delivered by a breath-actuated nebulizer designed to prevent release of the drug into the air.
Pain was measured on a visual analog scale at baseline and every 10 minutes for 40 minutes. Pain relief was superior with nebulized fentanyl, with a greater decrease from baseline at all time points. Of patients receiving nebulized fentanyl, 81% reported satisfaction, versus 25% of those receiving intravenous morphine. There were no significan…
Reviewing Author
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals